FT : Lars Windhorst companies to be auctioned after showjumping business dispute

Lars Windhorst companies to be auctioned after showjumping business dispute
Nearly two dozen groups owned by German financier scheduled to be sold next week

Nearly two dozen companies owned by German financier Lars Windhorst are due to be sold at a foreclosure auction this month, following a court order obtained by the family company of US billionaire Frank McCourt.

The auction is the latest attempt to claw back debts from the embattled businessman, who in recent years has been hit with multiple lawsuits by a series of creditors, with claims reaching into the hundreds of millions of euros. 

It is a setback for Windhorst, who has strived to turn around Tennor Holding, his ailing investment company, following the insolvency of a set of businesses it owned from medical robotics to luxury lingerie.

The auction is a result of a lengthy legal dispute between Windhorst and McCourt Global over the sale of its shares in an international show jumping competition to Tennor Holding.

A subsidiary of McCourt Global — which was founded by former Los Angeles Dodgers owner Frank McCourt — has obtained court orders allowing it to sell shares of Tennor Holding’s subsidiaries, in order to satisfy a debt of $106mn plus interest.

In 2020, Tennor Holding agreed to buy 50 per cent of show jumping business Global Champions from McCourt Global for €169mn, but then tried to back out citing financial difficulties due to the coronavirus pandemic.

Windhorst later agreed to proceed with the deal, but failed to comply with the payment terms relating to the share purchase, according to court records.  In April, a Dutch judge ruled that Windhorst could be detained if he travelled to the Netherlands for failing to comply with asset disclosure obligations in the case. 

The auction, slated for October 16 in Amsterdam,  involves 22 companies registered in the Netherlands and Switzerland. They include La Perla Fashion Holding, the previously listed parent company of luxury lingerie maker La Perla, whose UK arm was wound up in November last year over unpaid tax debt, as well as the company through which Windhorst previously owned Berlin football club Hertha Berlin, according to a public auction notice. It does not include Tennor Holding, Windhorst’s main investment company.

The notice warns that information about the companies that form part of the auction “may not be accurate or current”. Tennor and the companies had “not fully cooperated . . . despite various court orders to that effect”, and had “refused to allow the bailiff access to their share registers”, according to the document.

The notice further cautions that no assurances could be given that the companies owned any meaningful assets or that their shares had any value and that they were not free from encumbrances or third-party rights. 

McCourt Global declined to comment when asked how much money it hoped to raise from the auction.

Over the past decade, Windhorst raised billions of dollars from investment firms and wealthy individuals to fund his business ventures, primarily through bonds. However, he has faced multiple lawsuits from aggrieved creditors who have claimed that he failed to honour repayment agreements. 

Illiquid bonds linked to Windhorst’s companies were at the centre of a high-profile scandal at France’s H2O Asset Management, which was one of Windhorst’s major backers and at one time had an exposure of more than €2.3bn to Windhorst-linked securities.

In recent years, the financier has pursued new deals through a Swiss entity called Tennor International. In July, Nathaniel Rothschild, the scion of the Rothschild banking family, agreed to take a minority stake in Tennor and act as executive chairman.

Windhorst did not provide a comment for publication.

>>> Europe : Brokers Upgrades & Downgrades - 11th of October 2024 V2(+)

>>> Up
* ADP Raised to Overweight at JPMorgan; PT 150 euros
* Athens Intnl Airport Raised to Hold at Kepler Cheuvreux
* Barratt Redrow PLC Raised to Buy at Stifel; PT 540 pence (+)
* Crest Nicholson Raised to Buy at Stifel; PT 215 pence (+)
* Givaudan PT Raised to 4,950 Swiss francs at Bank Vontobel (+)
* GVS Raised to Neutral at Goldman; PT 7 euros
* Italgas Raised to Outperform at Grupo Santander; PT 6.30 euros
* Siemens Energy Raised to Neutral at JPMorgan; PT 32.80 euros

>>> Down
* Aena Cut to Neutral at JPMorgan; PT 213 euros
* ArcelorMittal Cut to Neutral at JPMorgan; PT 21 euros
* BASF Cut to Neutral at JPMorgan; PT 52 euros
* Ceres Power Cut to Neutral at Goldman; PT 296 pence
* Credit Agricole Cut to Neutral at Citi; PT 15.50 euros
* General Motors Cut to Hold at DZ Bank; PT $49 (+)
* Lanxess Cut to Underweight at JPMorgan (+)
* Mersen Cut to Add at IDMidcaps; PT 32 euros (+)
* Mobileye Cut to Neutral at Mizuho Securities on Growth Concerns
* PostNL Cut to Hold at ING; PT 1.20 euros
* Repsol Cut to Hold at DZ Bank; PT 13.10 euros
* Revenio Cut to Sell at Nordea; PT 28.50 euros
* Salzgitter Cut to Underweight at JPMorgan; PT 11.50 euros
* Thales Cut to Hold at Berenberg; PT 165 euros
* Trifork Group Cut to Hold at ABG; PT 105 kroner
* Vistry Group Cut to Neutral at JPMorgan; PT 970 pence
* Vistry Group Cut to Hold at Stifel; PT 950 pence (+)
* Walgreens Boots PT Cut to $7 from $9 at Morgan Stanley

>>> Initiation
* Alphabet Rated New Sector Outperform at Scotiabank
* CTS Eventim Rated New Buy at Deutsche Bank; PT 114 euros (+)
* Meta Platforms Rated New Sector Perform at Scotiabank

>>> Call
* CAB Payments Could See Re-Rating After StoneX Offer: Peel Hunt (+)
* Goldman’s Hammond Sees Earnings Driving AI Infrastructure Stocks (+)
* Morgan Stanley’s Wilson Says ‘It’s a Great Stock-Picking Market’
* Stellantis Management Changes Add Further Uncertanty, RBC Says
* Thales Downgraded at Berenberg on Challenges in Space Unit

>>> Stoxx 600 Pre-Market Indications

  • Volvo Car (8JO TH) +1.8%
  • Siemens Energy (ENR TH) +1.4%
    • Siemens Energy Raised to Neutral at JPMorgan; PT 32.80 euros
  • Zalando (ZAL TH) +0.5%
    • Zalando Results Beat, Guidance May Be Conservative: Street Wrap
  • L’Oreal (LOR TH) +0.4%
    • Watch French Stocks after PM Unveils New Taxes in 2025 Budget
  • BP (BPE5 TH) +0.4%
    • BP PLC BP. 3Q24 bp Trading Statement part 1 of 1
  • Veolia (VVD TH) -1.2%
  • Qiagen (QIA TH) -1.2%
  • Aixtron (AIXA TH) -1.8%
  • ArcelorMittal (ARRD TH) -2.2%
    • JPMorgan downgrades stock to neutral: APA
  • Lanxess (LXS TH) -4.4%
    • Street Insider: JPMorgan Downgrades Lanxess AG (LXS:GR) (LNXSF) to Underweight

>>> TradeGate Pre-Market Indications

DAX:
  • Siemens Energy (ENR TH) +1.4%
    • Siemens Energy Raised to Neutral at JPMorgan; PT 32.80 euros
  • Zalando (ZAL TH) +1.2%
    • Zalando Results Beat, Guidance May Be Conservative: Street Wrap
  • BASF (BAS TH) -0.8%
    • BASF Cut to Neutral at JPMorgan; PT 52 euros
MDAX:
  • Lanxess (LXS TH) -3.4%
    • JPMorgan cuts stock to underweight: APA
SDAX:
  • Mutares (MUX TH) +1.7%
  • Heidelberger Druck (HDD TH) +1.4%
  • RENK Group AG (R3NK TH) +1.2%
  • Ceconomy (CEC TH) -1.5%
  • DWS (DWS TH) -1.6%
  • Salzgitter (SZG TH) -2.2%
    • Salzgitter Cut to Underweight at JPMorgan; PT 11.50 euros

>>> Europe : Brokers Upgrades & Downgrades - 11th of October 2024

>>> Up
* ADP Raised to Overweight at JPMorgan; PT 150 euros
* Athens Intnl Airport Raised to Hold at Kepler Cheuvreux
* GVS Raised to Neutral at Goldman; PT 7 euros
* Italgas Raised to Outperform at Grupo Santander; PT 6.30 euros
* Siemens Energy Raised to Neutral at JPMorgan; PT 32.80 euros

>>> Down
* Aena Cut to Neutral at JPMorgan; PT 213 euros
* ArcelorMittal Cut to Neutral at JPMorgan; PT 21 euros
* BASF Cut to Neutral at JPMorgan; PT 52 euros
* Ceres Power Cut to Neutral at Goldman; PT 296 pence
* Credit Agricole Cut to Neutral at Citi; PT 15.50 euros
* Mobileye Cut to Neutral at Mizuho Securities on Growth Concerns
* PostNL Cut to Hold at ING; PT 1.20 euros
* Revenio Cut to Sell at Nordea; PT 6.70 euros
* Salzgitter Cut to Underweight at JPMorgan; PT 11.50 euros
* Thales Cut to Hold at Berenberg; PT 165 euros
* Trifork Group Cut to Hold at ABG; PT 105 kroner
* Vistry Group Cut to Neutral at JPMorgan; PT 970 pence
* Walgreens Boots PT Cut to $7 from $9 at Morgan Stanley

>>> Initiation
* Alphabet Rated New Sector Outperform at Scotiabank
* Meta Platforms Rated New Sector Perform at Scotiabank

>>> Call
* Morgan Stanley’s Wilson Says ‘It’s a Great Stock-Picking Market’
* Stellantis Management Changes Add Further Uncertanty, RBC Says
* Thales Downgraded at Berenberg on Challenges in Space Unit

>>> What to look at today - 11th of October 2024

Chinese stocks fell, underperforming their Asian peers as caution grows ahead of a key weekend briefing that may shed more light on Beijing’s fiscal stimulus.  The CSI 300 Index dropped 1.9% before the lunch break, reversing Thursday’s gains. Elsewhere in Asia, stocks rose in Japan and South Korea, sidestepping losses on Wall Street following hotter-than-expected core inflation that heightened the focus on the Federal Reserve’s next move. Australian equities were flat. All eyes are on a Saturday briefing, where China’s finance minister will likely announce more support measures to revive a slowing economy. Investors and analysts expect Beijing to deploy as much as 2 trillion yuan ($283 billion) in fresh fiscal stimulus as authorities seek to boost growth and restore confidence. The declines in Chinese stocks partly reflect “the risk of another disappointment with tomorrow’s Ministry of Finance briefing,” said Kieran Calder, head of equity research for Asia at Union Bancaire Privee in Singapore. “The MOF doesn’t approve extra budget or bond quota so there is uncertainty whether Saturday’s briefing can deliver new details on additional stimulus.” US equity futures also edged higher, after the S&P 500 fell 0.2% and the Nasdaq 100 dropped 0.1% Thursday. Hong Kong markets are closed Friday for a holiday. Treasuries were steady in early Asian trading after the two-year yield fell six basis points and its 10-year counterpart dropped by one basis point Thursday. Data released Thursday underscored the challenge facing the Fed. Underlying US inflation rose more than forecast in September in a sign of stalling progress in the fight to bring prices to target. Separate data showed applications for US unemployment benefits rose last week to the highest in over a year. Swaps market pricing indicating a potential Fed rate cut next month was little changed. Traders are pricing in a roughly 80% chance that the Fed will cut by 25 basis point when it meets in November. That compared with a fully priced-in move prior to last week’s strong US jobs data. Fed policymakers John Williams, Austan Goolsbee and Thomas Barkin were unfazed by the higher-than-forecast consumer price index, suggesting officials can continue lowering rates. The outlier was Raphael Bostic of the Atlanta Fed who indicated in an interview with the Wall Street Journal that in projections released in September he had called for one additional quarter-point cut across the Fed’s two remaining meetings in 2024. In currency markets, the yen was little changed at around 148 per dollar after strengthening on Thursday while an index of the dollar was steady. The South Korean won held gains against the dollar after the Bank of Korea cut its key interest rate by 25 basis points to 3.25%, as expected.
Oil edged lower, trimming some of its gains from Thursday when West Texas Intermediate futures climbed 3.6% as traders awaited Israel’s response to Iran’s missile attack. Investors are also gearing up for third-quarter US earnings later Friday from JPMorgan Chase & Co., Wells Fargo & Co and Bank of New York Mellon Corp. JPMorgan’s outlook for net interest income will be a major focus, after company executives tried to tamp down expectations for the key revenue source. As for Wells Fargo, investors may look for updates on its asset cap. BNY Mellon’s revenue likely grew 4% last quarter, the fastest pace in more than a year, according to Bloomberg Intelligence. US After Hours Quiet fter hours session; AEHR +10% higher on earnings; Healthcare stocks on radar after C.M.S. releases 2025 Medicare Advantage and Part D Star Ratings

Nikkei +0.56% Hang Seng Closed CSI -2.10% Shanghai -1.85% Shenzen -3.10%

Eur$ 1.0936 CNH 7.0807 CNY 7.0716 JPY 148.72 GBP 1.3049 CHF 0.8571 RUB 96.8250 TRY 34.2895 WTI$ 75.71 Gold 2,645.72 BTC 60,717 +1?50% ETH 2,411 +2%

S&P -0.04% Nasdaq -0.06% EuroStoxx +0.10% FTSE +0.20% Dax +0.08% SMI -0.02%

Macro :
- *BOSTIC SAYS DOOR OPEN TO SKIPPING RATE CUT IN NOV.: WSJ
- Morgan Stanley’s Wilson Says ‘It’s a Great Stock-Picking Market’
- UK Resumes Trade Talks With Switzerland in ‘Global Britain’ Push
- Renaissance Macro’s DeGraaf Says China Stocks Set to Surge 50%
- ONLY FANS SAYS IT PAID OUT $20 BILLION TO CREATORS SINCE 2016

Keep an eye on :
- AIR FP : Airbus faces pressure over supplies from Spirit Aero, sources say
- ATRLJB SS : Atrium Ljungberg 3Q Rental Income Beats Estimates
- AMD US : AMD Shares Slide as Investors Wait for Signs of AI Payoff
- APOTEA AB IPO : Swedish Online Pharmacy Apotea Is Said to Weigh $300 Million IPO
- BAC US : Berkshire’s BofA Stake Falls Below 10% Disclosure Theshold
- BAYN GY : Bayer Jury Awards $78 Mln in Philadelphia Roundup Case: Lawyers
- BBVA SM : BBVA Sees Sustainability as Top Investment Opportunity
- BMPS IM : Finint’s Marchi May Head Investor Group for Paschi Stake: Stampa
- CENER BB : Cenergy Offer Price for Capital Increase Set at €9/Share
- CEG US : Constellation Energy Recieved Waiver to Import Russian Uranium
- COPN Sw : Cosmo Pharmaceuticals Names Svetlana Sigalova CFO
- EDF FP : Italy Eyes Westinghouse, EDF Partnership for Nuclear Power: Rtrs
- EAPI FP : Euroapi, Sanofi Agree to €54M Product Capacity Reservation
- HAS LN : Hays 1Q Total Comparable Net Fees -14%
- ORSTED DC : Orsted Pulls Out of Danish Green Jet Fuel Project, Borsen Says
- ROG SW : FDA Approves Genentech’s Itovebi for Certain Cancer Treatments
- SBRY LN :Sainsbury Holder Qatar Holding Offers 109m Shares: Prices at GBp280/Share: Terms
- SRAIL SW : Stadler Rail to Start Temporary Short-Time Work in Altenrhein
- STLA US : Stellantis Ousts CFO in Effort to Stabilize Reeling Business
- TSLA US : SpaceX Launch Expansion Rebuffed By California Commission
- TSLA US : Musk Shows Tesla Cybercab, Sees Sub-$30,000 Cost and 2026 Debut
- TEVA IT : Teva Agrees to Pay $425 Million to Resolve Kickback Allegations
- THG LN : THG PLC 3Q Revenue GBP433.1M, PRICE AT 49 PENCE/SHR: TERMS
- TOM2 NA : TomTom 3Q Revenue Misses Estimates
- TGI US : Aircraft Parts Maker Triumph Group Is Said to Explore Sale
- TRYG DC : Tryg 3Q Insurance Service Result Beats Estimates
- ZAL GY : Zalando Boosts FY Adjusted Ebit Forecast, Beats Estimates
- FHZN SW : Zurich Airport Sept. Passenger Traffic +5%

FT : AMD rolls out new AI chip to rival Nvidia

AMD rolls out new AI chip to rival Nvidia
Chief executive Lisa Su believes Silicon Valley group is closing the performance gap with its larger competitor

AMD’s chief executive believes the chipmaker is closing the performance gap with Nvidia’s market-leading artificial intelligence processors, as it unveiled new products targeting a market worth hundreds of billions of dollars.

On Thursday the Silicon Valley-based group announced that its MI325X chip will roll out to customers in the fourth quarter of this year, saying it offers “industry-leading” performance compared to Nvidia’s current generation of H200 AI chips.

AMD’s next-generation MI350 chip, which aims to compete with Nvidia’s new Blackwell system, is on track to ship in the second half of 2025.

The US chipmaker has returned from the verge of bankruptcy a decade ago, when Lisa Su took over as chief executive, to emerge as the leading challenger to Nvidia’s grip on the infrastructure powering generative AI.

Su said her aim is for the company to become the “end-to-end AI leader” over the next 10 years. “You have to be extremely ambitious,” Su told the Financial Times. “This is the beginning, not the end of the AI race.” 

It comes as Nvidia’s customers are expected to start deploying Blackwell in the current quarter, with Microsoft this week saying it had become the first cloud provider to offer the latest GB200 chips to its customers.

While the so-called ‘hyperscalers’ — Microsoft, Google and Amazon — are also building their own in-house AI chips, AMD has become Nvidia’s closest competitor in the race to offer off-the-shelf AI chips.

It remains a distant second, however. AMD’s projected $4.5bn in AI chip sales for 2024 is small compared to the $26.3bn in AI data centre chip sales that Nvidia made in the quarter to the end of July alone.

But Su is confident that demand will only grow over the coming years. The company has predicted the total addressable market for AI chips will reach $400bn by 2027. 

“When we first started, that was viewed as a really big number,” Su said. “And I think people are moving towards our big number because of the tremendous demand there is for AI infrastructure.”

Chips are just one part of the infrastructure needed to build cutting-edge AI systems. AMD on Thursday also announced new networking technology and upgrades to its ROCm software toolkit, all of it aimed at offering AI infrastructure quickly and at scale.

“One of the things that we are really putting together is the end-to-end infrastructure for the data centre,” said Su. “People want a large cluster [of chips in a server] so you can train the largest language models.” 

Su, who has a PhD in electrical engineering from Massachusetts Institute of Technology, worked at Texas Instruments, IBM and Freescale Semiconductor before joining AMD in 2012 as a senior vice-president.  

When she took over as chief executive in 2014, AMD’s shares were languishing at around $4, with some analysts predicting it would be bankrupt in a few years as it struggled to compete with Intel.

Today, AMD has cornered a strong share of the server chip market and leapfrogged Intel on AI as it diversifies from its traditional PC business. AMD’s shares closed at $171 on Wednesday ahead of the announcement, giving it a market capitalisation of around $275bn — almost triple that of Intel.

Su sees AI as the primary driver of AMD’s next era of growth, and is seeking to land the same customers as Nvidia.

“People are really open to trying different architectures and seeing what fits their workload the best,” Su said. So far, both Microsoft and Meta have adopted AMD’s current generation of MI300 AI graphics processing units (GPUs).

Amazon, which is already a customer for AMD’s server CPUs, is likely to follow, Su said: “It’s a ‘point in time’ conversation.”

AMD’s approach parallels what Nvidia is doing with Blackwell, where it aims to sell not individual chips, but whole server racks made up of multiple chips, combined with Nvidia’s own networking equipment.

To catch up, AMD has pursued an aggressive investment and acquisition strategy, including the recent announcement of its $4.9bn acquisition of ZT Systems, which builds servers for the small group of AI hyperscalers.

In terms of potential regulatory reviews of the deal, Su said that “our current expectation is US-EU [checks], and there are a few other jurisdictions as well, but we don’t pass thresholds for China at the moment”.

FT : CD&R beats rivals in pursuit of €15.5bn Sanofi consumer health unit

CD&R beats rivals in pursuit of €15.5bn Sanofi consumer health unit
US private equity group nears deal for pharma spin-off after edging out PAI-led consortium

An offer from US private equity firm Clayton, Dubilier & Rice has beaten rivals, pursuing French pharmaceutical company Sanofi’s consumer healthcare division, in what is set to be the largest European healthcare deal this year, according to five people with direct knowledge of the process.

The American group on Thursday edged out a submission from a consortium led by French private equity firm PAI as it nears a deal with the French seller. Negotiations between Sanofi and CD&R will now continue, the people said. A deal could be reached within days but is not yet finalised.

CD&R’s offer values the business, which makes over-the-counter pain management and allergy medications, such as Doliprane and Allegra, at €15.5bn. Sanofi would keep a stake of about 50 per cent in the business with a view to selling it in the next few years, the people said.

Sanofi did not immediately respond to a request for comment. CD&R and PAI declined to comment. The offer was first reported by French newspaper Les Echos.

A transaction would be the latest of several sales of consumer divisions by pharmaceutical companies, as large groups in the sector seek to dispose of steady but low-earning businesses to focus their resources on the riskier but more lucrative field of drug development.

Sanofi has been exploring options for a sale or a potential float since it announced plans to separate the division a year ago. The Opella consumer division accounts for a tenth of the group’s total sales.

Chief executive Paul Hudson told the Financial Times last year that a future as a publicly listed entity was “the most likely path” for the division, but Sanofi seems to now be moving towards a private equity-led takeover.

In 2021, GSK and Pfizer listed their joint-venture consumer healthcare business Haleon in London, while Johnson & Johnson of the US separated off its consumer company Kenvue in 2022.

In keeping a large stake in Opella, Sanofi would seek to benefit from the reliable earnings it offers. GSK and Pfizer also both maintained large stakes in Haleon on listing, which they have since sold down.

Hudson will now focus on improving the company’s research and development output. The executive took investors by surprise last October when he decided to scrap Sanofi’s margin target for 2025 and unveiled plans to spend an additional €2bn on research in 2024 and 2025, leading to a 19 per cent hit to the company’s share price.

Sanofi is heavily reliant on income from its blockbuster asthma and allergy treatment Dupixent; developed by US drugmaker Regeneron, the drug accounted for almost a quarter of sales in 2023, but will lose patent protection around 2031.

Hudson has outlined 12 potential blockbuster candidates to shareholders in a bid to convince them that he can deliver on the company’s R&D ambitions.